Authors: Mustafa Orhan Bulut Ilker Kemal Yucel Mehmet Kucuk Sevket Balli Evic Zeynep Basar Ahmet Celebi
Publish Date: 2016/06/09
Volume: 37, Issue: 7, Pages: 1258-1265
Abstract
We aim to assess the safety feasibility and efficacy of the new NitOcclud ASDR NOASDR device From 2014 to 2015 transcatheter closure of atrial septal defect ASD using the NOASDR was performed in 30 consecutive patients The standard deployment technique as the left upper pulmonary vein approach was used in 25 patients Right upper pulmonary vein approach was required in five The median age was 6 years range 35–60 years and median weight was 215 kg 14–79 kg Implantation was successful in all patients The median size of devices was 16 mm 120–260 mm The mean device size/2D defect diameter ratio was 126 ± 009 112–140 The mean device size/color flow diameter ratio was 107 ± 006 range 10–122 Releasing problem was encountered in three patients A devicerelated erosion on the day after the closure was observed in one patient No further devicerelated complication erosion embolization or dislodgement of the device was encountered in a median followup period of 10 months range 2–14 months Complete occlusion has occurred in all at followup NOASDR is a feasible and effective device for use in the transcatheter occlusion of moderate to large secundum ASDs in selected patients The occurrence of the erosion on the right atrial roof may be due to the high localization of the device and the larger size of the right disk
Keywords: